Medicare Enrolled

Dr. Shahriar Pirouz, M.D.

Internal Medicine · San Luis Obispo, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
10 SANTA ROSA ST, San Luis Obispo, CA 93405
8055447426
In practice since 2007 (18 years)
NPI: 1922201508 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pirouz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pirouz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Pirouz

Dr. Shahriar Pirouz is an internal medicine specialist in San Luis Obispo, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Pirouz performed 4,104 Medicare services across 1,254 unique beneficiaries.

Between the years covered by Open Payments, Dr. Pirouz received a total of $29,411 from 35 pharmaceutical and/or device companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Pirouz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 7% volume in CA $29,411 industry payments

Medicare Practice Summary

Medicare Utilization ↗
4,104
Medicare services
Top 7% in CA for internal medicine
1,254
Unique beneficiaries
$92
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~228 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
2,421 $100 $450
Drug screening test
A laboratory test that uses a chemistry analyzer to detect the presence of drugs in a sample.
751 $60 $550
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
341 $69 $195
Injection into lower spine canal with imaging guidance
A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement.
116 $80 $800
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement.
94 $99 $2,213
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
86 $132 $375
Spine facet joint injection with imaging guidance, single level
An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement.
61 $106 $1,505
Facet joint nerve destruction, single joint
A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals.
42 $215 $2,507
Spinal neurostimulator electrode insertion
A procedure to place an electrode array into the spine through the skin. The electrode is used to deliver electrical stimulation to the nervous system.
39 $251 $3,750
Injection of anesthetic or steroid into sacroiliac joint with imaging guidance
This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection.
37 $81 $1,443
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
30 $36 $551
Spinal injection with imaging guidance
A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location.
25 $87 $1,612
Facet joint injection, second level, with imaging guidance
An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated.
22 $41 $1,219
Facet joint injection, second level, with imaging
An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement.
20 $48 $1,125
Facet joint nerve destruction, single joint
This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint.
19 $197 $2,274
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$29,411
Total received (2018-2024)
Avg $4,202/year across 7 years
Top 4% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
35
Companies
351
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$24,910 (84.7%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,501 (15.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$19,366
2023
$6,335
2022
$1,436
2021
$384
2020
$319
2019
$588
2018
$982

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$18,916
Boston Scientific Corporation
$246
BIOTRONIK NRO, Inc.
$91
Nalu Medical, Inc.
$31
PFIZER INC.
$19
VERTEX PHARMACEUTICALS INCORPORATED
$17
AppliedVR Inc
$16
ABBVIE INC.
$16
Avanos Medical
$14
Top 3 companies account for 99.4% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$26,262
Medtronic USA, Inc.
$1,080
Boston Scientific Corporation
$332
PFIZER INC.
$195
ABBVIE INC.
$184
Abbott Laboratories
$153
Assertio Therapeutics, Inc.
$136
SI-BONE, Inc.
$101
Almatica Pharma LLC
$92
BIOTRONIK NRO, Inc.
$91
Teva Pharmaceuticals USA, Inc.
$67
PAINTEQ LLC
$60
Nevro Corp.
$58
AbbVie Inc.
$55
Heron Therapeutics, Inc.
$48
TerSera Therapeutics LLC
$43
GRT US Holding, Inc.
$42
Purdue Pharma L.P.
$35
Allergan, Inc.
$35
Amgen Inc.
$33
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$31
Nalu Medical, Inc.
$31
Alnylam Pharmaceuticals Inc.
$29
Supernus Pharmaceuticals, Inc.
$27
Daiichi Sankyo Inc.
$27
Averitas Pharma Inc.
$21
Relievant Medsystems, Inc.
$19
BioDelivery Sciences International, Inc.
$18
VERTEX PHARMACEUTICALS INCORPORATED
$17
Scilex Pharmaceuticals Inc.
$16
AppliedVR Inc
$16
DePuy Synthes Sales Inc.
$16
ASSERTIO THERAPEUTICS, Inc.
$15
Avanos Medical
$14
Forte Bio-Pharma LLC
$13
Top 3 companies account for 94.1% of all-time payments
Associated products mentioned in payments ›
ACCURIAN · ADAPTIVESTIM · AJOVY · ASCENDA · Aimovig · BELBUCA · BOTOX · Cambia · EVENITY · GENERAL - PAIN MANAGEMENT · GENERAL - THERAPIES · GENVISC 850 SODIUM HYALURONATE · GIVLAARI · GRALISE · Gralise · HTX-011 · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · KYPHON EXPRESS II KYPHOPAK TRAY · LYRICA · MONOVISC · Morphabond ER · NALOCET · NAPRELAN · NURTEC ODT · Nalu Neurostimulation System · Octrode SCS Leads · PAINTEQ · Prialt · Proclaim Family of SCS IPGs · Prospera · QULIPTA · QUTENZA · Qutenza · RESTORE · RESTORESENSORSURESCAN · RelieVRx · SCS leads · SPECTRA WAVEWRITER · SYMPROIC · SYNCHROMED · SYNCHROMEDII · Senza · Senza Spinal Cord Stimulation System · TROKENDI XR · UBRELVY · VANTA ADAPTIVESTIM · ZTLido · Zipsor
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (85%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in internal medicine and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 4% for internal medicine in CA.

Looking for an internal medicine specialist in San Luis Obispo?
Compare internal medicine physicians in the San Luis Obispo area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
103
Per 100K population
36.6
County median income
$93,398
Nearest hospital
ADVENTIST HEALTH SIERRA VISTA
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Pirouz is a clinical cardiology specialist, with above-average Medicare volume (top 7% in CA), with speaking/promotional industry engagement in the top 4% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Pirouz experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Pirouz performed 2,421 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pirouz receive payments from pharmaceutical companies?
Yes. Dr. Pirouz received a total of $29,411 from 35 companies across 351 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pirouz's costs compare to other internal medicine physicians in San Luis Obispo?
Dr. Pirouz's average Medicare payment per service is $92. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pirouz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →